Recent Comments

Comment RSS

Type 2 Diabetes News and Research RSS Feed - Type 2 Diabetes News and Research

Type 2 diabetes, formerly called adult-onset or noninsulindependent diabetes, is the most common form of diabetes. People can develop type 2 diabetes at any age, even during childhood. This form of diabetes usually begins with insulin resistance, a condition in which fat, muscle, and liver cells do not use insulin properly. At first, the pancreas keeps up with the added demand by producing more insulin. In time, however, it loses the ability to secrete enough insulin in response to meals. People who are overweight and inactive are more likely to develop type 2 diabetes. Treatment includes taking diabetes medicines, making wise food choices, exercising regularly, controlling blood pressure and cholesterol, and taking aspirin daily—for some.

Obesity: A major contributor to the development of Type 2 diabetes

21. November 2009 01:38
"Many Americans have a very limited understanding of the basic facts about diabetes, as well as the serious consequences for health that accompany the disease," commented Sue McLaughlin, RD, CDE, President, Health Care & Education, American Diabetes Association, in a media alert. She blames the problem on a combination of factors including denial of the disease and promotion of inaccurate information or myths surrounding diabetes. [More]

ESC and EASD organize Joint Scientific Forum in China to address optimal treatment strategies for diabetes

21. November 2009 00:12
As a result of successful events organised last year, a second Joint Scientific Forum, organised by the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), two of the most respected professional medical organisations in Europe, will be held from 27-29 November at three venues across China - Beijing, Shanghai and Guangzhou. [More]

Nutrisystem announces support for the Stop Diabetes movement

20. November 2009 11:37
Nutrisystem, Inc., a leading developer of weight loss products and services, today announced its company-wide support for the recently launched Stop DiabetesSM movement from the American Diabetes Association. On the heels of the successful launch of Nutrisystem D, its program designed to help people with type 2 diabetes lose weight, Nutrisystem has implemented a $5.00 contribution for every person who shares their story on the American Diabetes Association’s Stop Diabetes website, up to $100,000 through December 31, 2009. [More]

Posted in: Medical Condition News

Tags: , , , , , ,

Data from second positive pivotal study of PSD502 for treatment of PE presented

20. November 2009 00:52
At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora")., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). [More]

New market research report on Australia's pharmaceuticals and healthcare industry

20. November 2009 00:20
Research and Markets (http://www.researchandmarkets.com/research/27e3e3/australia_pharmace) has announced the addition of the "Australia Pharmaceuticals and Healthcare Report Q1 2010" report to their offering. [More]

Posted in: Healthcare News | Pharmaceutical News

Tags: , , ,

American Diabetes Association launches redesigned diabetes website

19. November 2009 23:14
To meet the changing needs of people affected by this growing epidemic, the American Diabetes Association has launched a completely redesigned www.diabetes.org in English and Spanish. Even though diabetes is a growing epidemic, a recent survey conducted by the Association showed that Americans received a failing grade in diabetes awareness. [More]

Positive results from Echo Therapeutics' Symphony tCGM System study

19. November 2009 08:48
Echo Therapeutics, Inc., a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, today announced positive results of a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 Diabetes. [More]

Posted in: Device / Technology News | Medical Condition News

Tags: , , , ,

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

19. November 2009 08:36
At the annual meeting of the Sexual Medicine Society of North America, Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC, today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). [More]

Positive results from REVIVE, a phase 3 pivotal study of avanafil announced

18. November 2009 07:16
VIVUS, Inc. today announced positive results from REVIVE (TA-301), a phase 3 pivotal study evaluating the safety and efficacy of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED), in 646 patients. [More]

Drug therapy offers substantial cost savings than angioplasty

18. November 2009 00:43
Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD. [More]

CONTOUR USB meter available for purchase through Walgreens online pharmacy

18. November 2009 00:13
Bayer's CONTOUR® USB meter, the first blood glucose monitor that connects directly to a PC or MAC -- providing users with instant access to information and trends about their blood sugar levels -- is now available for purchase through Walgreens online pharmacy and will soon also be available online through CVS and Walmart. [More]

Global Alliance for Chronic Diseases announces targets

17. November 2009 23:53
The Global Alliance for Chronic Diseases (GACD) on Monday outlined plans "to invest tens of millions of dollars in heart and lung disease studies in a battle against a global epidemic of chronic disease," over five years, Reuters reports. [More]

Posted in: Disease/Infection News

Tags: , , , , , , ,

Global Alliance for Chronic Disease to fight against chronic non-communicable diseases

17. November 2009 04:53
An alliance of institutions collectively managing an estimated 80 percent of all public health research funding worldwide today announced their first targets for concerted action in the fight against "chronic non-communicable diseases" (CNCDs). [More]

deCODE genetics files voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code

17. November 2009 04:03
deCODE genetics, Inc. (Nasdaq: DCGN) today announced that it has filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code with the United States Bankruptcy Court for the District of Delaware to facilitate the sale of substantially all of its assets. deCODE is continuing to operate its business and manage its properties as a debtor-in-possession pursuant to Sections 1107 and 1108 of the Bankruptcy Code. [More]

Antioxidant found in vegetables can protect cells from damage caused by infection and injury

17. November 2009 01:29
Scientists at the University of Pennsylvania School of Medicine discovered that a dietary antioxidant found in such vegetables as broccoli and cauliflower protects cells from damage caused by chemicals generated during the body's inflammatory response to infection and injury. The finding has implications for such inflammation-based disorders as cystic fibrosis (CF), diabetes, heart disease, and neurodegeneration. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.